Fox Run Management’s BioNTech BNTX Stock Holding History

Fox Run Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$411K	Buy	+4,184	New	+$406K	0.05%	649
2025 Q4	–	Sell	-9,750	Closed	-$962K	–	931
2025 Q3	$962K	Buy	9,750 +6,906	+243%	+$738K	0.15%	228
2025 Q2	$303K	Buy	+2,844	New	+$287K	0.05%	634
2024 Q3	–	Sell	-8,183	Closed	-$658K	–	817
2024 Q2	$658K	Buy	+8,183	New	+$748K	0.12%	312
2023 Q4	–	Sell	-7,921	Closed	-$861K	–	741
2023 Q3	$861K	Buy	+7,921	New	+$876K	0.25%	107
2022 Q3	–	Sell	-1,542	Closed	-$230K	–	614
2022 Q2	$230K	Sell	1,542 -118	-7%	-$18K	0.11%	383
2022 Q1	$283K	Buy	+1,660	New	+$279K	0.16%	296

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Fox Run Management's BNTX Position: Q3 2026 in Review

Fox Run Management opened a new position in BioNTech (BNTX) in Q3 2026: 4,184 shares worth $411K. The stake represents 0.05% of the portfolio and ranks #649 among its holdings. This is a return to the name: Fox Run Management previously reported a position in BNTX as recently as Q3 2025.

Fox Run Management first reported a position in BNTX in Q1 2022 and has held it in 7 quarters since. The position peaked at $962K in Q3 2025. 201 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

Fox Run Management held 4,184 shares of BioNTech worth $411K as of Q3 2026.
BioNTech was a new Fox Run Management position in Q3 2026.
BioNTech made up 0.05% of Fox Run Management's portfolio in Q3 2026, its #649 holding.
Fox Run Management first reported a position in BioNTech in Q1 2022 and has held it in 7 quarters since.
Fox Run Management's BioNTech position peaked at $962K in Q3 2025.
201 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.